These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
118 related items for PubMed ID: 12087882
1. [Analysis of lipid plasma spectrum and basic parameters of red cell membranes in patients with metabolic syndrome and ischemic heart disease]. Medvedeva IV, Dorodneva EF, Pugacheva TA, Belokorylova LV, Shorokhova TD, Ushakova MA. Klin Med (Mosk); 2002; 80(5):27-30. PubMed ID: 12087882 [Abstract] [Full Text] [Related]
2. [Specific features of lipid atherogenic modification in patients with ischemic heart disease and diabetes mellitus]. Syrkin AL, Azizova OA, Drinitsina SV, Solovi'eva NP, Frenkel' EE, Savchenkova AP, Kliuchnikova TI. Klin Med (Mosk); 2001; 79(4):25-9. PubMed ID: 11496733 [Abstract] [Full Text] [Related]
3. [Apolipoprotein B100 as a risk factor of acute coronary syndrome and this risk factor effect on arterial hypertension in patients with ischemic heart disease]. Arabidze GG, Pokrovskiĭ SN, Afanas'eva MI, Tebloev KI, Memetov KA, Skriabina EO. Ter Arkh; 2005; 77(9):35-9. PubMed ID: 16281487 [Abstract] [Full Text] [Related]
4. [Clinical efficacy of combined therapy with enalapril + trimetazidine in patients with hypertension comorbid with ischemic heart disease and metabolic disturbances]. Petelina TI, Gapon LI, Bakhmatova IuA, Zhevagina IA. Ter Arkh; 2005; 77(8):19-23. PubMed ID: 16206600 [Abstract] [Full Text] [Related]
5. [Disordered lipid metabolism and the morphofunctional instability of the erythrocyte membranes in patients with terminal kidney failure]. Grinshteĭn IuI, Tereshchenko VP, Tereshchenko IuA, Romanova VIa. Ter Arkh; 1990; 62(6):84-8. PubMed ID: 2218935 [Abstract] [Full Text] [Related]
6. [Hormonal dysregulation of lipid metabolism in pathogenesis of ischemic heart disease]. Sokolov EI, Perova NV. Klin Med (Mosk); 2004; 82(1):27-31. PubMed ID: 15022592 [Abstract] [Full Text] [Related]
7. [Risk factors of ischemic heart disease and lipid metabolism in cardiorespiratory diseases]. Avdeeva EV, Koval'skaia EA, Vostrikova OG. Klin Med (Mosk); 2000; 78(3):25-8. PubMed ID: 10790960 [Abstract] [Full Text] [Related]
8. Influence of plasma and erythrocyte factors on red blood cell aggregation in survivors of acute myocardial infarction. Vayá A, Falcó C, Réganon E, Vila V, Martínez-Sales V, Corella D, Contreras MT, Aznar J. Thromb Haemost; 2004 Feb; 91(2):354-9. PubMed ID: 14961164 [Abstract] [Full Text] [Related]
9. [Total and lipid-bound sialic acids in the blood in primary and secondary hyperlipoproteinemias]. Tvorogova MG, Rozhkova TA, Lupanov VP, Liakishev AA, Titov VN. Ter Arkh; 1997 Feb; 69(1):23-5. PubMed ID: 9163043 [Abstract] [Full Text] [Related]
10. [Localization of vessel lesions in arteriosclerosis and blood lipid composition]. Lipovetskiĭ BM, Vinogradova TV. Ter Arkh; 2002 Feb; 74(2):55-7. PubMed ID: 11899828 [Abstract] [Full Text] [Related]
11. Impact of metabolic syndrome's components on the development of cardiovascular disease in a Jordanian cohort with metabolic syndrome. Haddad FH, Mahafza SM. Saudi Med J; 2008 Sep; 29(9):1299-305. PubMed ID: 18813416 [Abstract] [Full Text] [Related]
12. Prevalence of metabolic syndrome in heart transplant patients: role of previous cardiopathy and years since the procedure--the TRACA study. Cordero Fort A, Gavira JJ, Alegría-Barrero E, Castaño S, Martín A, Ubilla M, Mastrobuoni S, Alegría Ezquerra E, Herreros J, Rábago G. J Heart Lung Transplant; 2006 Oct; 25(10):1192-8. PubMed ID: 17045931 [Abstract] [Full Text] [Related]
14. Metabolic syndrome and ischemic heart disease in gout. Vázquez-Mellado J, García CG, Vázquez SG, Medrano G, Ornelas M, Alcocer L, Marquez A, Burgos-Vargas R. J Clin Rheumatol; 2004 Jun; 10(3):105-9. PubMed ID: 17043480 [Abstract] [Full Text] [Related]
15. Triglycerides, high-density lipoprotein cholesterol, and risk of ischemic heart disease: a view from the Copenhagen Male Study. Jeppesen J. Metab Syndr Relat Disord; 2003 Mar; 1(1):33-53. PubMed ID: 18370624 [Abstract] [Full Text] [Related]
16. Oxidative stress, antioxidant status and lipid profile in ischemic heart disease patients from western region of Nepal. Maharjan BR, Jha JC, Adhikari D, Akila, Risal S, Alurkar VM, Singh PP. Nepal Med Coll J; 2008 Mar; 10(1):20-4. PubMed ID: 18700625 [Abstract] [Full Text] [Related]
17. [Changes in the indices of lipid metabolism in patients with ischemic heart disease occupied in natural gas fields]. Tin'kov AN, Makshantsev SS, Prokof'ev AB, Perepelkin SV. Gig Sanit; 2003 Mar; (3):21-3. PubMed ID: 12852033 [Abstract] [Full Text] [Related]
18. Levels of non-high density lipoprotein cholesterol (non-HDL-C) in patients with ischaemic heart disease. Tauheed S, Shoaib S, ul Haque MN. J Ayub Med Coll Abbottabad; 2003 Mar; 15(1):33-4. PubMed ID: 12870314 [Abstract] [Full Text] [Related]
19. [Correlations between electrophysiological myocardial remodeling and parameters of free radical oxidation in patients with various forms of ischemic heart disease]. Drinitsina SV, Azizova OA, Piriazev AP, Korinevich AIu, Solov'eva NP, Ivanov GG, Lopukhin IuM. Ter Arkh; 2006 Mar; 78(12):27-35. PubMed ID: 17294860 [Abstract] [Full Text] [Related]
20. Relationship between adiponectin, glycemic control and blood lipids in diabetic type 2 postmenopausal women with and without complication of ischemic heart disease. Jaleel F, Jaleel A, Aftab J, Rahman MA. Clin Chim Acta; 2006 Aug; 370(1-2):76-81. PubMed ID: 16516182 [Abstract] [Full Text] [Related] Page: [Next] [New Search]